Quick Answer
Definitive Healthcare Corp. reported Research And Development Expense of $34.78 million for the year ending 2025.
- Definitive Healthcare Corp. showed a decrease of -4.8% in Research And Development Expense from 2024 to 2025.
- This data is from Definitive Healthcare Corp.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Definitive Healthcare Corp.'s Research And Development Expense has grown by 214.4%.
- Historical annual values: Fiscal year 2025: $34.78 million | Fiscal year 2024: $36.52 million | Fiscal year 2023: $42.44 million | Fiscal year 2022: $34.89 million | Fiscal year 2021: $18.57 million | Fiscal year 2020: $11.06 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: